Citadel Group — Director's Dealing 2022

Dec 9, 2022

National Storage Mechanism | Additional information

RNS Number : 2646J

Citadel Group

09 December 2022

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)	Citadel Group
Company dealt in	HORIZON THERAPEUTICS PLC
Class of relevant security to which the dealings being disclosed relate (Note 2)	Common Stock ISIN IE00BQPVQZ61
Date of dealing	08 December, 2022

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

	Long	Short
ISIN IE00BQPVQZ61	Number        (%)	Number      (%)
(1) Relevant securities	2,857,355 (1.26%)	171,641 (0.07%)
(2) Derivatives (other than options)	0 (0.00%)	0 (0.00%)
(3) Options and agreements to purchase/sell	329,164 (0.14%)	152,715 (0.06%)
Total	3,186,519 (1.40%)	324,356 (0.14%)

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale ISIN IE00BQPVQZ61	Number of securities	Price per unit (Note 5)
Buy Transaction	6,600	96.9200 USD
Buy Transaction	3,485	96.9200 USD
Buy Transaction	1,642	96.9200 USD
Buy Transaction	100	97.4425 USD
Buy Transaction	1,742	96.9100 USD
Buy Transaction	1,252	97.1648 USD
Buy Transaction	508	96.4608 USD
Buy Transaction	200	96.2600 USD
Buy Transaction	137	96.9349 USD
Buy Transaction	100	98.1600 USD
Buy Transaction	21,368	96.9761 USD
Buy Transaction	8,700	96.9798 USD
Buy Transaction	3,962	97.0849 USD
Buy Transaction	3,396	96.9924 USD
Buy Transaction	1,926	96.9100 USD
Buy Transaction	1,856	97.1134 USD
Buy Transaction	1,205	97.2628 USD
Buy Transaction	818	96.9100 USD
Buy Transaction	610	96.9100 USD
Buy Transaction	577	97.3706 USD
Buy Transaction	556	97.1804 USD
Buy Transaction	294	96.9100 USD
Buy Transaction	273	96.9100 USD
Buy Transaction	209	96.9100 USD
Buy Transaction	55	96.9100 USD
Buy Transaction	49	96.9100 USD
Sell Transaction	3,787	96.9321 USD
Sell Transaction	4,508	97.5226 USD
Sell Transaction	11,894	96.9630 USD
Sell Transaction	13,051	97.3819 USD
Sell Transaction	64	97.6700 USD
Sell Transaction	120	96.0083 USD
Sell Transaction	301	98.2476 USD
Sell Transaction	1,191	97.5401 USD
DVP Transaction	1,642	96.9200 USD
DVP Transaction	3,485	96.9200 USD
DVP Transaction	6,600	96.9200 USD
RVP Transaction	6,600	96.9200 USD
RVP Transaction	3,485	96.9200 USD
RVP Transaction	1,642	96.9200 USD

(b)        Derivatives transactions (other than options transactions)

Product name, e.g. CFD ISIN IE00BQPVQZ61	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit (Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/ received per unit (Note 5)
Call Option	Buy Transaction	10	115.0000 DOL.C-USAA	Amer Opt	17/02/2023	5.9600 USD
Call Option	Buy Transaction	11	115.0000 DOL.C-USAA	Amer Opt	17/02/2023	5.9200 USD
Call Option	Buy Transaction	3	115.0000 DOL.C-USAA	Amer Opt	17/02/2023	5.7000 USD
Call Option	Buy Transaction	2	115.0000 DOL.C-USAA	Amer Opt	17/02/2023	5.8000 USD
Call Option	Sell Transaction	2	125.0000 DOL.C-USAA	Amer Opt	17/02/2023	1.8500 USD
Call Option	Sell Transaction	8	125.0000 DOL.C-USAA	Amer Opt	17/02/2023	1.9000 USD
Call Option	Sell Transaction	22	125.0000 DOL.C-USAA	Amer Opt	17/02/2023	1.9600 USD
Call Option	Sell Transaction	20	125.0000 DOL.C-USAA	Amer Opt	17/02/2023	1.9800 USD
Put Option	DVP Transaction	500	80.0000 DOL.C-USAA	Amer Opt	20/01/2023	3.1460 USD
Put Option	RVP Transaction	500	80.0000 DOL.C-USAA	Amer Opt	20/01/2023	3.1460 USD

(ii)        Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit       (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure:	09 December, 2022
Contact name:	Paula Sharp
Telephone number:	020 7645 9700
If a connected EFM, name of offeree/offeror with which connected	n/a
If a connected EFM, state nature of connection (Note 10)	n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEUPGBUPUPPGCB